{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:41:11Z","timestamp":1783492871396,"version":"3.55.0"},"reference-count":23,"publisher":"Japanese Society of Toxicology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2011]]},"DOI":"10.2131\/jts.36.445","type":"journal-article","created":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T06:22:32Z","timestamp":1312179752000},"page":"445-452","source":"Crossref","is-referenced-by-count":21,"title":["Cerivastatin induces type-I fiber-, not type-II fiber-, predominant muscular toxicity in the young male F344 rats"],"prefix":"10.2131","volume":"36","author":[{"given":"Hisakuni","family":"Obayashi","sequence":"first","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Nezu","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatsue","family":"Yokota","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kiyosawa","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Mori","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Maeda","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Tani","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunao","family":"Manabe","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sanbuissho","sequence":"additional","affiliation":[{"name":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Amelink, G.J. and B&auml;r, P.R. (1986): Exercise-induced muscle protein leakage in the rat. Effects of hormonal manipulation. J. Neurol. Sci., <b>76<\/b>, 61-68.","DOI":"10.1016\/0022-510X(86)90142-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bergman, M., Salman, H., Djaldetti, M., Alexandrova, S., Punsky, I. and Bessler, H. (2003): Ultrastructure of mouse striated muscle fibers following pravastatin administration. J. Muscle Res. Cell. Motil., <b>24<\/b>, 417-420.","DOI":"10.1023\/A:1027367022415"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Biral, D., Ballarin, F., Toscano, I., Salviati, G., Yu, F., Larsson, L. and Betto, R. (1999): Gender- and thyroid hormone-related transitions of essential myosin light chain isoform expression in rat soleus muscle during ageing. Acta. Physiol. Scand., <b>167<\/b>, 317-323.","DOI":"10.1046\/j.1365-201x.1999.00621.x"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1996.04178.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Degens, H., Yu, F., Li, X. and Larsson, L. (1998): Effects of age and gender on shortening velocity and myosin isoforms in single rat muscle fibres. Acta. Physiol. Scand., <b>163<\/b>, 33-40.","DOI":"10.1046\/j.1365-201x.1998.00329.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Farmer, J.A. (2001): Learning from the cerivastatin experience. Lancet, <b>358<\/b>, 1383-1385.","DOI":"10.1016\/S0140-6736(01)06489-3"},{"key":"7","unstructured":"Gambelli, S., Dotti, M.T., Malandrini, A., Mondelli, M., Stromillo, M.L., Gaudiano, C. and Federico, A. (2004): Mitochondrial alterations in muscle biopsies of patients on statin therapy. J. Submicrosc. Cytol. Pathol., <b>36<\/b>, 85-89."},{"key":"8","unstructured":"Gauthier, G.F. (1986): Skeletal muscle fiber types. In: Myology: basic and clinical (Engel, A.G. and Banker, B.Q., eds.), pp.255-283, McGRAW-HILL BOOK COMPANY, Cleveland, Ohio."},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-006-6235-z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Nishimoto, T., Tozawa, R., Amano, Y., Wada, T., Imura, Y. and Sugiyama, Y. (2003): Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytes. Biochem. Pharmacol., <b>66<\/b>, 2133-2139.","DOI":"10.1016\/j.bcp.2003.08.011"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199606000-00016"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Riggs, J.E., Schochet, S.S.Jr., Kopitnik, T.A. and Gutmann, L. (1986): Target fibers in multiple sclerosis: implications for pathogenesis. Neurology, <b>36<\/b>, 297-298.","DOI":"10.1212\/WNL.36.2.297"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.10.033"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2003.08.013"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfi305"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.10.108"},{"issue":"3","key":"18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0022-3565(25)24759-0","volume":"257","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200202143460720"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.13.1681"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Waclawik, A.J., Lindal, S. and Engel, A.G. (1993): Experimental lovastatin myopathy. J. Neuropathol. Exp. Neurol., <b>52<\/b>, 542-549.","DOI":"10.1097\/00005072-199309000-00012"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Westwood, F.R., Bigley, A., Randall, K., Marsden, A.M. and Scott, R.C. (2005): Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity. Toxicol. Pathol., <b>33<\/b>, 246-257.","DOI":"10.1080\/01926230590908213"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Westwood, F.R., Scott, R.C., Marsden, A.M., Bigley, A. and Randall, K. (2008): Rosuvastatin: characterization of induced myopathy in the rat. Toxicol. Pathol., <b>36<\/b>, 345-352.","DOI":"10.1177\/0192623307311412"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jts\/36\/4\/36_4_445\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T23:48:11Z","timestamp":1741391291000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jts\/36\/4\/36_4_445\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.36.445","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}